Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
1:16-cv-00987
Overview
Parties
Defendant
Mylan Pharmaceuticals Inc. Operating Company
Represented By
4 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Plaintiff
Takeda Pharmaceuticals U.S.A., Inc. Operating Company
Represented By
7 Attorneys ListedWomble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Womble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Takeda Pharmaceuticals U.S.A., Inc. v. Scilex Pharmaceuticals Inc.
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.
Takeda Pharmaceuticals USA Inc. v. Par Pharmaceutical Companies Inc.
Takeda Pharmaceuticals U.S.A. Inc. v. Par Pharmaceutical Inc.
Patents Involved
There are 16 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7906519
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-08-18
Issued: 2011-03-15
|
Active (3.7 yrs remaining)
Expires: 2030-08-18
|
|
|
US7935731
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2010-05-25
Issued: 2011-05-03
|
Active (3.5 yrs remaining)
Expires: 2030-05-25
|
|
|
US8093298
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2011-05-18
Issued: 2012-01-10
|
Active (4.5 yrs remaining)
Expires: 2031-05-18
|
|
|
US7964648
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-01-15
Issued: 2011-06-21
|
Active (3.2 yrs remaining)
Expires: 2030-01-15
|
|
|
US8093297
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2011-04-22
Issued: 2012-01-10
|
Active (4.4 yrs remaining)
Expires: 2031-04-22
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
17
Dispositive
10
Granted
1
Denied
0
Pending / Review
13
Motions by Category
Key Dispositive Motions & Rulings